CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.
09 May 2025
09 May 2025
Total investments received (USD): 154.98M
Round value (USD): 120M
Company: CellCentric
Related deals
Tropic raised a $105 million Series C led by Forbion and Corteva, joined by IQ Capital, Just Climate, ABN Amro, Invest International, Temasek, Five Seasons
Investments
13 March 2026
Dark Blue Therapeutics was acquired for $840 million by Amgen in the USA
Secondary
06 December 2025
Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.
Investments
07 November 2025
Belgium
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain